Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garrett M Brodeur

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2012
A three-gene expression signature model for risk stratification of patients with neuroblastomaIdoia Garcia, Gemma Mayol, José Ríos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force reportTom Monclair, Garrett M Brodeur, Peter F Ambros, et al.
The New England Journal of Medicine|November 25, 2005
Chromosome 1p and 11q deletions and outcome in neuroblastomaEdward F Attiyeh, Wendy B London, Yael P Mossé, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2025
Update on Retinoblastoma Predisposition and Surveillance Recommendations for ChildrenJunne Kamihara, Jaclyn Schienda, Rose B McGee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2017
Retinoblastoma and Neuroblastoma Predisposition and SurveillanceJunne Kamihara, Franck Bourdeaut, William D Foulkes, et al.
Frontiers in Endocrinology|March 10, 2023
<i>DICER1</i> RNase IIIb domain mutations trigger widespread miRNA dysregulation and MAPK activation in pediatric thyroid cancerJulio C Ricarte-Filho, Victoria Casado-Medrano, Erin Reichenberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2012
Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641Douglas R Strother, Wendy B London, Mary Lou Schmidt, et al.
Journal of the National Cancer Institute|May 3, 2024
Identification of TP53 germline variants in pediatric patients undergoing tumor testing: strategy and prevalenceMinjie Luo, Derek Wong, Kristin Zelley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2025
Update on Tumor Surveillance for Children with Hereditary Pheochromocytoma/Paraganglioma SyndromesSurya P Rednam, Junne Kamihara, Kerri D Becktell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2025
Update on Surveillance in Von Hippel-Lindau DiseaseSurya P Rednam, Kerri D Becktell, Anita Villani, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2012
A three-gene expression signature model for risk stratification of patients with neuroblastomaIdoia Garcia, Gemma Mayol, José Ríos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force reportTom Monclair, Garrett M Brodeur, Peter F Ambros, et al.
The New England Journal of Medicine|November 25, 2005
Chromosome 1p and 11q deletions and outcome in neuroblastomaEdward F Attiyeh, Wendy B London, Yael P Mossé, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2025
Update on Retinoblastoma Predisposition and Surveillance Recommendations for ChildrenJunne Kamihara, Jaclyn Schienda, Rose B McGee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2017
Retinoblastoma and Neuroblastoma Predisposition and SurveillanceJunne Kamihara, Franck Bourdeaut, William D Foulkes, et al.
Frontiers in Endocrinology|March 10, 2023
<i>DICER1</i> RNase IIIb domain mutations trigger widespread miRNA dysregulation and MAPK activation in pediatric thyroid cancerJulio C Ricarte-Filho, Victoria Casado-Medrano, Erin Reichenberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2012
Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641Douglas R Strother, Wendy B London, Mary Lou Schmidt, et al.
Journal of the National Cancer Institute|May 3, 2024
Identification of TP53 germline variants in pediatric patients undergoing tumor testing: strategy and prevalenceMinjie Luo, Derek Wong, Kristin Zelley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2025
Update on Tumor Surveillance for Children with Hereditary Pheochromocytoma/Paraganglioma SyndromesSurya P Rednam, Junne Kamihara, Kerri D Becktell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2025
Update on Surveillance in Von Hippel-Lindau DiseaseSurya P Rednam, Kerri D Becktell, Anita Villani, et al.
Pageof 9